Health in Upper-middle income (World Bank)

149 indicators covering health for Upper-middle income (World Bank).

Indicator	Latest	Year	10-yr change	Rank
Low birth weight prevalence	8.4%	2020	up 3.7%	11th
Inactivated first-dose polio vaccine (IPV1) immunization coverage	90.0%	2025	up 275.0%	5th
Low birth weight number	2,809	2020	down 14.8%	9th
Concentrations of fine particulate matter	26.61	2023	down 33.3%	10th
New or unknown treatment history cases: Pulmonary, bacteriologically	1.06 million	2023	up 33.4%	5th
Number of children aged 6-59 months with anaemia	47,786	2019	down 2.9%	6th
Prevalence of anaemia in children aged 6-59 months	23.3%	2019	down 6.0%	7th
Number of deaths attributed to non-communicable diseases, by type of	4.25 million	2019	up 21.0%	2nd
HIV-positive TB patients on ART (antiretroviral therapy)	86.0%	2024	up 13.2%	6th
Treatment success rate for patients treated for MDR-TB	66.0%	2022	up 24.5%	9th
Treatment success rate: HIV-positive TB cases	70	2023	down 2.8%	8th
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc)	83.0%	2025	—	5th
Number of prevalent tuberculosis cases	2.40 million	2014	down 25.0%	5th
Japanese encephalitis - number of reported cases	424	2025	down 65.3%	5th
Neonates protected at birth against neonatal tetanus (PAB)	90.0%	2022	up 3.4%	6th
HPV immunization coverage estimates among primary target cohort (9-14)	32.0%	2025	up 68.4%	6th
Tuberculosis - new and relapse cases	1.79 million	2011	up 52.7%	4th
Total number of notified TB cases	1.60 million	2014	down 3.5%	4th
Underweight numbers among children under 5 years of age (millions)	3,962	2024	down 53.5%	9th
Underweight prevalence among children under 5 years of age (%)	2.6%	2024	down 38.1%	9th
Smear-positive tuberculosis treatment-success rate	87.0%	2011	up 10.1%	5th
Insufficiently active	83.87	2016	down 0.8%	5th
Yellow fever vaccine (YFV) immunization coverage among 1-year olds	68.0%	2025	up 36.0%	2nd
Preterm birth rate	7.69	2020	up 3.9%	14th
Preterm birth	2.17 million	2020	down 16.6%	8th
Treatment success rate: XDR-TB cases	65	2022	up 195.5%	6th
Confirmed cases of MDR-TB	32,679	2012	up 316.7%	3rd
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)	84.0%	2014	down 16.0%	6th
Confirmed cases of MDR-TB started treatment for MDR-TB	64.0%	2012	—	8th